Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study to Investigate Acute Respiratory Virus Infections in Patients at High Risk for Severe Illness

NCT05661604 is registered in ClinicalTrials.gov with Janssen Research & Development, LLC as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05661604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study to Investigate Acute Respiratory Virus Infections in Patients at High Risk for Severe Illness
Lead sponsor
Janssen Research & Development, LLC
Phase
Observational
Overall status
Completed
Start date
January 19, 2023
Completion date
March 31, 2024
Enrollment
140 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory viral infection